Literature DB >> 8482290

Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.

J H Ehrich1, J Brodehl.   

Abstract

Two regimens of steroid treatment for the initial attack of idiopathic nephrotic syndrome (NS) in children were compared in a controlled prospective multi-centre study. Long prednisone therapy consisted of 60 mg/m2 per 24 h for 6 weeks, followed by alternate day 40 mg/m2 per 48 h for 6 weeks. The standard prednisone therapy was 60 mg/m2 per 24 h for 4 weeks, followed by 40 mg/m2 per 48 h for 4 weeks. A total of 71 children with an initial attack of idiopathic NS were allocated at random to the two groups. The cumulative rate of patients with sustained remissions after 2 years was significantly higher after the long course than after the standard treatment (49% vs 19%, P = 0.0079). The mean relapse rate per patient at intervals of 3, 6 and 12 months was lower in the long-course prednisone group than in the standard prednisone group, and the proportion of children with frequent relapses during any subsequent 6 months period was lower in the long-course group than in the standard group (29% vs 57%, P = 0.03). Mild side-effects of corticosteroid therapy were observed more frequently after long-course prednisone treatment. It is concluded that long-course prednisone therapy of the initial attack of steroid responsive NS is preferable to the standard regimen because it reduces the rate of subsequent relapses without increasing the risk for severe steroidal side-effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482290     DOI: 10.1007/bf01956754

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Prolonged intermittent steroid therapy for nephrosis in children and adults.

Authors:  K LANGE; E WASSERMAN; L B SLOBODY
Journal:  J Am Med Assoc       Date:  1958-09-27

2.  Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis.

Authors:  C N Lam; G C Arneil
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

3.  Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children.

Authors:  M Abramowicz; H L Barnett; C M Edelmann; I Greifer; O Kobayashi; G C Arneil; B A Barron; G Gordillo-P; N Hallman; H A Tiddens
Journal:  Lancet       Date:  1970-05-09       Impact factor: 79.321

4.  Management of the nephrotic syndrome.

Authors:  G C Arneil
Journal:  Arch Dis Child       Date:  1968-04       Impact factor: 3.791

5.  Thrombosis, nephrosis, and corticosteroid therapy.

Authors:  E Lieberman; E Heuser; G S Gilchrist; G N Donnell; B H Landing
Journal:  J Pediatr       Date:  1968-09       Impact factor: 4.406

6.  Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1982-10       Impact factor: 4.406

7.  Glucocorticoids in renal disease. Theoretical basis, consequences and efficacy of use in the pediatric patient.

Authors:  A L Friedman; R W Chesney
Journal:  Am J Nephrol       Date:  1982       Impact factor: 3.754

8.  Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie".

Authors: 
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

9.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

10.  The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN).

Authors:  J Brodehl; H P Krohn; J H Ehrich
Journal:  Klin Padiatr       Date:  1982 May-Jun       Impact factor: 1.349

View more
  64 in total

1.  Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome.

Authors:  René Frydensbjerg Andersen; Nana Thrane; Karen Noergaard; Lene Rytter; Bente Jespersen; Søren Rittig
Journal:  Pediatr Nephrol       Date:  2010-05-06       Impact factor: 3.714

2.  Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.

Authors:  Vaishnavi Raman; Sriram Krishnamurthy; K T Harichandrakumar
Journal:  Pediatr Nephrol       Date:  2016-01-12       Impact factor: 3.714

3.  Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome.

Authors:  Mohan Shenoy; Nicholas D Plant; Malcolm A Lewis; Mark G Bradbury; Rachel Lennon; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2010-01-27       Impact factor: 3.714

4.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

5.  Dosing of glucocorticosteroids in nephrotic syndrome.

Authors:  Otto Mehls; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2011-09-09       Impact factor: 3.714

Review 6.  New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.

Authors:  Michael van Husen; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2011-01-13       Impact factor: 3.714

7.  Corticosteroids for the initial episode of steroid-sensitive nephrotic syndrome.

Authors:  Elisabeth M Hodson; Deirdre Hahn; Jonathan C Craig
Journal:  Pediatr Nephrol       Date:  2015-04-26       Impact factor: 3.714

8.  Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids.

Authors:  Anna M Wasilewska; Walentyna M Zoch-Zwierz; Mirosława Pietruczuk
Journal:  Eur J Pediatr       Date:  2006-12       Impact factor: 3.183

9.  Low birth weight, but not postnatal weight gain, aggravates the course of nephrotic syndrome.

Authors:  Christian Plank; Iris Ostreicher; Katalin Dittrich; Rüdiger Waldherr; Manfred Voigt; Kerstin Amann; Wolfgang Rascher; Jörg Dötsch
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

Review 10.  Treatment of steroid-resistant nephrotic syndrome in the genomic era.

Authors:  Adam R Bensimhon; Anna E Williams; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2018-10-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.